Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gershenson

Showing results (11-20 of 617) with videos related to

Pageof 62
Sort By:
Cancer Investigation|April 1, 1999
Contemporary treatment of borderline ovarian tumorsD M Gershenson
Obstetrics and Gynecology Clinics of North America|March 1, 1994
Primary cytoreduction for advanced epithelial ovarian cancerD M Gershenson
Cancer Journal (Sudbury, Mass.)|January 5, 2002
Why American women are not receiving state-of-the-art gynecologic cancer careD M Gershenson
Mutation Research|May 1, 1986
Viruses as environmental mutagenic factorsS M Gershenson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The life and times of low-grade serous carcinoma of the ovaryDavid M Gershenson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of ovarian germ cell tumorsDavid M Gershenson
Seminars in Surgical Oncology|July 1, 1994
Chemotherapy of ovarian germ cell tumors and sex cord stromal tumorsD M Gershenson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Low-grade serous carcinoma of the ovary or peritoneumD M Gershenson
Oncology (Williston Park, N.Y.)|July 12, 2002
Irinotecan in epithelial ovarian cancerDavid M Gershenson
Clinical Obstetrics and Gynecology|February 21, 2012
Treatment of ovarian cancer in young womenDavid M Gershenson
Pageof 62

Showing results (11-20 of 617) with videos related to

Sort By:
Pageof 62
Cancer Investigation|April 1, 1999
Contemporary treatment of borderline ovarian tumorsD M Gershenson
Obstetrics and Gynecology Clinics of North America|March 1, 1994
Primary cytoreduction for advanced epithelial ovarian cancerD M Gershenson
Cancer Journal (Sudbury, Mass.)|January 5, 2002
Why American women are not receiving state-of-the-art gynecologic cancer careD M Gershenson
Mutation Research|May 1, 1986
Viruses as environmental mutagenic factorsS M Gershenson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The life and times of low-grade serous carcinoma of the ovaryDavid M Gershenson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of ovarian germ cell tumorsDavid M Gershenson
Seminars in Surgical Oncology|July 1, 1994
Chemotherapy of ovarian germ cell tumors and sex cord stromal tumorsD M Gershenson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Low-grade serous carcinoma of the ovary or peritoneumD M Gershenson
Oncology (Williston Park, N.Y.)|July 12, 2002
Irinotecan in epithelial ovarian cancerDavid M Gershenson
Clinical Obstetrics and Gynecology|February 21, 2012
Treatment of ovarian cancer in young womenDavid M Gershenson
Pageof 62